Why Don’t Doctors Recommend Them Now?
1. Vitamin B3 cannot be patented.
2. Vitamin B3 is incredibly cheap.
3. If taken correctly there are no side effects.
3. Vitamin B3 might cure the disease.
That is the ultimate worst case scenario for ‘Big Pharma’ and it’s salesman (= doctors).
(There are still great doctors out there but for many reasons their numbers are decreasing dramatically.)
There are a lot of junk science studies circulating out there that now want to tell us that vitamins have no effect.
Look who conducted the study and on whose payroll they are. There are only around 5% independent scientists out there. The other 95% are ‘bought’ by corporations. Any disease ‘can’ be cured with Alternative Medicine.
(OMNS, December 9, 2008) The news media recently reported that “huge doses of an ordinary vitamin appeared to eliminate memory problems in mice with the rodent equivalent of Alzheimer’s disease.” They then quickly added that “scientists aren’t ready to recommend that people try the vitamin on their own outside of normal doses.” (1)
In other words, extra-large amounts of a vitamin are helpful, so don’t you take them!
That does not even pass the straight-faced test. So what’s the story?
Researchers at the University of California at Irvine gave the human dose equivalent of 2,000 to 3,000 mg of vitamin B3 to mice with Alzheimer’s. (2) It worked. Kim Green, one of the researchers, is quoted as saying, “Cognitively, they were cured. They performed as if they’d never developed the disease.”
Specifically, the study employed large amounts of nicotinamide, the vitamin B3 widely found in foods such as meat, poultry, fish, nuts and seeds. Nicotinamide is also the form of niacin found, in far greater quantity, in dietary supplements. It is more commonly known as niacinamide. It is inexpensive and its safety is long established. The most common side effect of niacinamide in very high doses is nausea. This can be eliminated by taking less, by using regular niacin instead, which may cause a warm flush, or choosing inositol hexaniacinate, which does not. They are all vitamin B3.
HealthDay Reporter mentioned how cheap the vitamin is; the study authors “bought a year’s supply for $30” and noted that it “appears to be safe.” Even so, one author said that “I wouldn’t advocate people rush out and eat grams of this stuff each day.” (1)
The BBC quoted Rebecca Wood, Chief Executive of the UK Alzheimer’s Research Trust, who said, “Until the human research was completed, people should not start taking the supplement. . . . people should be wary about changing their diet or taking supplements. In high doses vitamin B3 can be toxic.” (3)
The Irish Times reiterated it: “People have been cautioned about rushing out to buy high dose vitamin B3 supplements in an attempt to prevent memory loss . . . The warnings came today one day on from the announcement . . .Vitamins in high doses can be toxic.” (4)
Their choice of words is quaint but hardly accurate. There is no wild “rush;” half of the population already takes food supplements. And as for “toxic,” niacin isn’t. Canadian psychiatrist Abram Hoffer, M.D., asserts that it is actually remarkably safe. “There have been no deaths from niacin supplements,” Dr. Hoffer says. “The LD 50 (the dosage that would kill half of those taking it) for dogs is 5,000-6,000 milligrams per kilogram body weight. That is equivalent to almost a pound of niacin per day for a human. No human takes 375,000 milligrams of niacin a day. They would be nauseous long before reaching a harmful dose.” Dr. Hoffer conducted the first double-blind, placebo-controlled clinical trials of niacin. He adds, “Niacin is not liver toxic. Niacin therapy increases liver function tests. But this elevation means that the liver is active. It does not indicate an underlying liver pathology.”
The medical literature repeatedly confirms niacin’s safety. Indeed, for over 50 years, nutritional (orthomolecular) physicians have used vitamin B3 in doses as high as tens of thousands of milligrams per day. Cardiologists frequently give patients thousands of milligrams of niacin daily to lower cholesterol. Niacin is preferred because its safety margin is so very large. The American Association of Poison Control Centers’ Toxic Exposure Surveillance System annual reports indicates there is not even one death per year due to niacin in any of its forms. (5)
One the other hand, there are 140,000 deaths annually attributable to properly prescribed prescription drugs. (6) And this figure is just for one year, and just for the USA. Furthermore, when overdoses, incorrect prescription, and adverse drug interactions are figured in, total drug fatalities number over a quarter of a million dead. Each year.
The BBC’s curious mention that we should even be “wary about changing our diets” is especially odd. More and more scientists think our much-in-need-of-improvement diets are what contribute more than anything to developing Alzheimer’s. “There appears to be a statistically significant link between a low dietary intake of niacin and a high risk of developing Alzheimer’s disease. A study of the niacin intake of 6158 Chicago residents 65 years of age or older established that the lower the daily intake of niacin, the greater the risk of becoming an Alzheimer’s disease patient.” The group with the highest daily intake of niacin had a 70 percent decrease in incidence of this disease compared to the lowest group. “The most compelling evidence to date is that early memory loss can be reversed by the ascorbate (vitamin C) minerals. Greater Alzheimer’s disease risk also has been linked to low dietary intake of vitamin E and of fish.” (7)
Nutrient deficiency of long standing may create a nutrient dependency. A nutrient dependency is an exaggerated need for the missing nutrient, a need not met by dietary intakes or even by low-dose supplementation. Robert P. Heaney, M.D., uses the term “long latency deficiency diseases” to describe illnesses that fit this description. He writes: “Inadequate intakes of many nutrients are now recognized as contributing to several of the major chronic diseases that affect the populations of the industrialized nations. Often taking many years to manifest themselves, these disease outcomes should be thought of as long-latency deficiency diseases. . . Because the intakes required to prevent many of the long-latency disorders are higher than those required to prevent the respective index diseases, recommendations based solely on preventing the index diseases are no longer biologically defensible.” (8) Where pathology already exists, unusually large quantities of vitamins may be needed to repair damaged tissue. Thirty-five years ago, in another paper, Hoffer wrote: “The borderline between vitamin deficiency and vitamin-dependency conditions is merely a quantitative one when one considers prevention and cure.” (9)
As there is no recognized cure for Alzheimer’s, prevention is vital. In their article, the Irish Times does admit that “Healthy mice fed the vitamins also outperformed mice on a normal diet” and quoted study co-author Frank LaFerla saying that “This suggests that not only is it good for Alzheimer’s disease, but if normal people take it, some aspects of their memory might improve.” (4) And study author Green added, “If we combine this with other things already out there, we’d probably see a large effect.”
The US Alzheimer’s Association’s Dr. Ralph Nixon has said that previous research has suggested that vitamins such as vitamin E, vitamin C and vitamin B12 may help people lower their risk of developing Alzheimer’s disease. At their website (although you have to search for it), the Alzheimer’s Association says, “Vitamins may be helpful. There is some indication that vitamins, such as vitamin E, or vitamins E and C together, vitamin B12 and folate may be important in lowering your risk of developing Alzheimer’s. . . One large federally funded study (10) showed that vitamin E slightly delayed loss of ability to carry out daily activities and placement in residential care.”
But overall, at their website http://www.alz.org/index.asp the Alzheimer’s Association has strikingly little to say about vitamins, and they hasten to tell people that “No one should use vitamin E to treat Alzheimer’s disease except under the supervision of a physician.” ( http://www.alz.org/alzheimers_disease_10428.asp ) “They write as if these safe vitamins are dangerous drugs, not be used without a doctor’s consent,” comments Dr. Hoffer. “I have been using them for decades.”
Niacin and nerves go together. Orthomolecular physicians have found niacin and other nutrients to be an effective treatment for obsessive compulsive disorder, anxiety, bipolar disorder, depression, psychotic behavior, and schizophrenia. New research confirms that niacinamide (the same form of B3 used in the Alzheimer’s research) “profoundly prevents the degeneration of demyelinated axons and improves the behavioral deficits” in animals with an illness very similar to multiple sclerosis. (11)
A measure of journalistic caution is understandable, especially with ever-new promises for pharmaceutical products. Drugs routinely used to treat Alzheimer’s Disease have had a disappointing, even dismal success rate. So when nutrition may be the better answer, foot-dragging is inexplicable, even inexcusable. Nutrients are vastly safer than drugs. Unjustified, needlessly negative opinionating is out of place. Over 5 million Americans now have Alzheimer’s disease, and the number is estimated to reach 14 million by 2050. Potentially, 9 million people would benefit later from niacin now.
“Man is a food-dependent creature,” wrote University of Alabama professor of medicine Emanuel Cheraskin, M.D.. “If you don’t feed him, he will die. If you feed him improperly, part of him will die.”
When that part is the brain, it is dangerous to delay the use of optimum nutrition.
(1) Vitamin Holds Promise for Alzheimer’s Disease. Randy Dotinga, HealthDay Reporter, Nov 5, 2008.
http://www.washingtonpost.com/wp-dyn/content/article/2008/11/05/AR2008110502796.html and also http://health.yahoo.com/news/healthday/vitaminholdspromiseforalzheimersdisease.html
(2) Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM. Nicotinamide restores cognition in Alzheimer’s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci. 2008 Nov 5;28(45):11500-10.
(3) BBC, 5 Nov 2008. http://news.bbc.co.uk/2/hi/health/7710365.stm
(4) Donnellan E. Caution urged over using vitamin B3 to treat Alzheimer’s. Wed, Nov 05, 2008. http://www.irishtimes.com/newspaper/breaking/2008/1105/breaking91.htm
(5) Annual Reports of the American Association of Poison Control Centers’ National Poisoning and Exposure Database (formerly known as the Toxic Exposure Surveillance System). AAPCC, 3201 New Mexico Avenue, Ste. 330, Washington, DC 20016. Download any report from1983-2006 at http://www.aapcc.org/dnn/NPDS/AnnualReports/tabid/125/Default.aspx free of charge. The “Vitamin” category is usually near the end of the report.
(6) Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997 Jan 22-29;277(4):301-6.
(7) 21. Hoffer A and Foster HD. Feel Better, Live Longer With Vitamin B-3: Nutrient Deficiency and Dependency. CCNM Press, 2007. ISBN-10: 1897025246; ISBN-13: 978-1897025246. Also: Foster HD. What Really Causes Alzheimer’s Disease. Trafford, 2004. ISBN 1-4120-4921-0.
(8) Heaney RP: Long-latency deficiency disease: insights from calcium and vitamin D. Am J Clin Nutr. 2003; Nov; 78(5):912-9.
(9) Hoffer A. Mechanism of action of nicotinic acid and nicotinamide in the treatment of schizophrenia. In: Hawkins D and Pauling L: Orthomolecular Psychiatry: Treatment of Schizophrenia. San Francisco: W.H. Freeman. 1973; p. 202-262.
(10) Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216-22
(11) Kaneko S, Wang J, Kaneko M, Yiu G, Hurrell JM, Chitnis T, Khoury SJ, He Z. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J Neurosci. 2006 Sep 20;26(38):9794-804. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed See also: Vitamins fight multiple sclerosis. Orthomolecular Medicine News Service, October 4, 2006.
For More Information:
A complete copy of Dr. Harold D. Foster’s What Really Causes Alzheimer’s Disease is available in PDF format, free of charge: http://www.hdfoster.com/Foster_Alzheimers.pdf
To access a free archive of peer-reviewed medical journal papers on the safety and efficacy of vitamin therapy: http://orthomolecular.org/library/jom/
Review of nutritional approaches to Alzheimer’s Disease: http://www.doctoryourself.com/alzheimer.html
Klenner FR. Response of peripheral and central nerve pathology to mega-doses of the vitamin B-complex and other metabolites. Journal of Applied Nutrition, 1973. http://www.tldp.com/issue/11_00/klenner.htm
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, and Scherr PA. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer’s disease in a biracial community study. Journal of the American Medical Association, 2002. 287(24), 3230-3237.
Morris MC, Evans DA, Bienias PA, Scherr A, Tangney CC, Hebert LE, Bennett DA, Wilson RS, and Aggarwal N. Dietary Niacin and the Risk of Incident Alzheimer’s Disease and of Cognitive Decline. J Neurology, Psychiatry 2004; 75: 1093-1099.
Bobkova NV. The impact of mineral ascorbates on memory loss. Paper presented at the III World Congress on Vitamin C, 2001, Committee for World Health, Victoria, BC, Canada.
Galeev A, Kazakova A, Zherebker E, Dana E, and Dana R. Mineral ascorbates improve memory and cognitive functions in older individuals with pre-Alzheimer’s symptoms. Copy of paper given to authors by R. Dana and E. Dana, Committee for World Health, 20331 Lake Forest Drive, Suite C-15, Lake Forest, California 92630, USA.
Bobkova NV, Nesterova IV, Dana E, Nesterov VI, Aleksandrova IIu, Medvinskaia NI, and Samokhia AN (2003). Morpho-functional changes of neurons in temporal cortex in comparison with spatial memory in bulbectomized mice after treatment with minerals and ascorbates. Morfologiia, 123(3), 27-31. [In Russian]
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, and Witteman JC (2002). Dietary intake of antioxidants and risk of Alzheimer’s disease: Food for thought. Journal of the American Medical Association, 287(24), 3223-3229.
Grant WB. Dietary links to Alzheimer’s disease: 1999 update. Journal of Alzheimer’s disease, 1999, 1(4,5), 197-201.
Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Jean-François Dartigues JF, and Renaud S (2002). Fish, meat, and risk of dementia: Cohort study. British Medical Journal, 325, 932-933.
Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, de Jager C, Budge MM, Smith AD. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008 Sep 9;71(11):826-32.
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Carolyn Dean, M.D., N.D.
Damien Downing, M.D.
Harold D. Foster, Ph.D.
Steve Hickey, Ph.D.
Abram Hoffer, M.D., Ph.D.
James A. Jackson, PhD
Bo H. Jonsson, MD, Ph.D
Thomas Levy, M.D., J.D.
Erik Paterson, M.D.
Gert E. Shuitemaker, Ph.D.
Andrew W. Saul, Ph.D., Editor and contact person. Email: [email protected]
Orthomolecular Medicine News Service, December 9, 2008